Human mecC-Carrying MRSA: Clinical Implications and Risk Factors.

ABSTRACT: A new methicillin resistance gene, named mecC, was first described in 2011 in both humans and animals. Since then, this gene has been detected in different production and free-living animals and as an agent causing infections in some humans. The possible impact that these isolates can have in clinical settings remains unknown. The current available information about mecC-carrying methicillin resistant S. aureus (MRSA) isolates obtained from human samples was analyzed in order to establish its possible clinical implications as well as to determine the infection types associated with this resistance mechanism, the characteristics of these mecC-carrying isolates, their possible relation with animals and the presence of other risk factors. Until now, most human mecC-MRSA infections have been r

SUBMITTER: Lozano C 

PROVIDER: S-EPMC7589452 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature